The relationship between executive dysfunction and neuropsychiatric symptoms in patients with Korsakoff’s syndrome

Abstract

Objective: Patients with Korsakoff's syndrome (KS) show executive dysfunction and neuropsychiatric symptoms. This study investigates whether specific executive subcomponents (shifting, updating, and inhibition) predict variance in neuropsychiatric symptoms. We hypothesized that shifting deficits, in particular, are associated with neuropsychiatric symptoms. Method: Forty-seven patients participated (mean age 61.5; 11 women). Executive function (EF) was measured using six component-specific tasks. Neuropsychiatric symptoms were measured with the Neuropsychiatric Inventory -Questionnaire (NPI-Q). General cognitive functioning was assessed with the Montreal Cognitive Assessment (MoCA). First, factor analysis was conducted to examine shared variance across the EF tasks. Subsequently, a regression analysis was performed with the EF factors and the MoCA as predictors and the NPI-Q as the dependent variable. It was also investigated whether an interaction effect between the EF factors and the MoCA was present. Results: The prevalence of neuropsychiatric symptoms was high (85.7% of the KS patients showed at least one symptom). A twofactor model was extracted with a shifting-specific factor and a combined updating/inhibition factor. The overall regression model was not significant, and no interaction was found between the EF factors and general cognitive functioning. However, a significant relationship between general cognitive functioning and neuropsychiatric symptoms (r ¼ -.43; p <.01) was detected. Conclusions: Results point at an association between neuropsychiatric symptoms and general cognitive functioning. Possibly, diminished cognitive differentiation in these patients with severe ARTICLE HISTORY cognitive dysfunction accounts for the absence of a significant association between EF and neuropsychiatric symptoms. While the results should be interpreted with caution due to a limited sample size, the found association highlights the need to further unravel the underlying cognitive mechanisms of neuropsychiatric symptoms in patients with KS.

Prevalences and Indications of Psychotropic Drug Prescriptions in Nursing Home Residents with Korsakoff Syndrome

“…This might lead to delusion-like ideas. Combined with a lack of awareness, they often do not understand why they would need any help, resulting in resistance, frustration and agitation [35]. Therefore, it could be possible that PD are felt ne-cessary to treat behavioral symptoms such as suspicion and agitation.…”

Self-Reported Pain and Pain Observations in People with Korsakoff’s Syndrome: A Pilot Study

“…The perception of pain is regarded as a multidimensional complex experience comprising sensory, affective, and cognitive aspects that can lead to physiological, emotional, and behavioral responses [12]. The pain pathway, the spinothalamic tract, consists of the medial and the lateral pain system [13]. The medial pain system plays a crucial part in the motivational-affective features of pain, involving memory, expectation and emotion, and cognitive-evaluative features, the autonomic-neuroendocrine responses evoked by pain [13,14].…”

“…The pain pathway, the spinothalamic tract, consists of the medial and the lateral pain system [13]. The medial pain system plays a crucial part in the motivational-affective features of pain, involving memory, expectation and emotion, and cognitive-evaluative features, the autonomic-neuroendocrine responses evoked by pain [13,14]. However, the lateral pain system is particularly involved in the sensorydiscriminative features of pain such as the recognition of location, intensity, and nature of nociceptive stimuli (e.g., sharp or dull) [14].…”